Devyser and QIAGEN collaborate on pre-analytical workflow for fetal RHD screening
Fetal derived cell-free DNA (cfDNA) is a key analyte for determining fetal RHD status in plasma...
News | April 15, 2019
Devyser is extremely proud to have been recognized as one of Sweden’s best workplaces (Small Organisations). Across all categories Devyser was the only nominated workplace from the biotech/medtech industry in Sweden. This is a wonderful recognition of the teamwork that our colleagues exhibit every day, thank you to all who make Devyser the wonderful workplace that it is!
Fetal derived cell-free DNA (cfDNA) is a key analyte for determining fetal RHD status in plasma...
Read More
Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted...
Read More
“The first quarter of the year saw continued strong growth, record gross margin and the launching...
Read More
Devyser is today announcing that the company’s clinical testing laboratory in Roswell in Atlanta,...
Read More